Skip to content
Recall Observatory FDA recall evidence

Drug product

Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06

D-0100-2023

December 12, 2022

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 91295
Status
Terminated
Classification
Class II
Quantity
16,056 30 count bottles
Official record key
drug-enforcement:D-0100-2023

Official wording

Reason: Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.

Code information: Lot # A200171, Exp 12/2023

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications